GLP-1 Medications Infographic
US$ 27.60
kff glp-1 Medicaid Coverage of and Spending on GLP-1s Telehealth Booms as Demand for
Description
Equally important is close collaboration with psychiatry
The short answer, based on current clinical data, is no
The Salt Lake City metropolitan area has an adult obesity rate of 27%, and demand for GLP-1 medications like semaglutide (Wegovy) and tirzepatide (Zepbound) continues to grow
This has become a vital pathway for access
For patients with diabetes, stopping may require adjustments to other glucose-lowering medications to maintain glycemic control
Results vary from patient to patient
